Modulation of bone marrow cell functions in vitro by bestatin (ubenimex)

Biomed Pharmacother. 1991;45(2-3):81-6. doi: 10.1016/0753-3322(91)90126-e.

Abstract

Bestatin (ubenimex), the microbial leucil-aminopeptidase B inhibitor, has been shown previously to stimulate both interleukin-1 (IL-1) and IL-2 production and to enhance T-cell, as well as macrophage mediated immunoreaction when administered in vivo in mice. Here we show that although Bestatin has no direct growth stimulatory activity, it enhances the growth of GM-CFU populations in semisolide culture and stimulates the cell production in liquide organotypic Hematon cultures in synergy with recombinant human GM-CSF. In long term human bone marrow culture Bestatin accelerated the adipocytic differentiation among colony forming stroma cells (F-CFU). Our data provide further evidences that Bestatin may interact with the hemopoietic cell renewal system at different levels of biological organisation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibiotics, Antineoplastic / pharmacology*
  • Cell Differentiation / drug effects
  • Cells, Cultured
  • Drug Synergism
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • In Vitro Techniques
  • Leucine / analogs & derivatives*
  • Leucine / pharmacology

Substances

  • Antibiotics, Antineoplastic
  • Granulocyte Colony-Stimulating Factor
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Leucine
  • ubenimex